Facebook
X
LinkedIn
ForwardJohannes Czernin, M.D.
Dr. Johannes Czernin received his MD degree from the University of Vienna in 1983. He was board certified in Internal Medicine in AUSTRIA in 1989 and in Nuclear Medicine in 1996 in the USA. He was named Director of Nuclear Medicine at the David Geffen School of Medicine at UCLA in 1996 and currently serves as the Chief of the Ahmanson Translational Theranostics Division at UCLA. The Division includes the Nuclear Medicine Clinic, a clinical imaging research program, a drug and probe development program with a strong underpinning in tumor biology, and a preclinical imaging center. The Division collaborates within the department of molecular and medical pharmacology and across several other departments including medicine, surgery, radiology, neurology, pathology and others. Dr. Czernin is currently Editor-in-Chief of the Journal of Nuclear Medicine and is a past president of the Academy of Molecular Imaging. He has published more than 280 peer-reviewed research papers.
Financial relationships
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.